MAPT as a predisposing gene for sporadic amyotrophic lateral sclerosis in the Chinese Han population

Neural Regeneration Research

Volumn 8, Issue 33, 2013, Pages 3116-3123

  Fang, Pu ^a   Xu, Wen Yuan ^a   Wu, Cheng Si ^a   Zhu, Min ^a   Li, Xiao Bing ^a   Hong, Dao Jun ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Chinese Han population; Genotype; MAPT; Microtubule associated protein Tau gene; Neural regeneration; Neuroregeneration; Sporadic amyotrophic lateral sclerosis

Indexed keywords

TAU PROTEIN;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROMYOGRAPHY; FEMALE; FOLLOW UP; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MAPT GENE; RETROSPECTIVE STUDY; SURVIVAL TIME;

EID: 84889773987     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2013.33.005     Document Type: Article

References (36)

1. Kiernan MC, Vucic S, Cheah BC, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377(9769):942-955.
2. Costa J, Swash M, de Carvalho M. Awaji criteria for the diagnosis of amyotrophic lateral sclerosis: a systematic review. Arch Neurol. 2012.
3. Inghilleri M, Iacovelli E. Clinical neurophysiology in ALS. Arch Ital Biol. 2011;149(1):57-63.
4. De Chiara G, Marcocci ME, Sgarbanti R, et al. Infectious agents and neurodegeneration. Mol Neurobiol. 2012; 46(3):614-638.
5. Pasinelli P, Brown RH. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci. 2006;7(9):710-723.
6. Cooper-Knock J, Kirby J, Ferraiuolo L, et al. Gene expression profiling in human neurodegenerative disease. Nat Rev Neurol. 2012;8(9):518-530.
7. Lambrechts D, Storkebaum E, Morimoto M, et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet. 2003;34(4):383-394.
8. Bloem BR, Scheffer H, van Nuenen BF, et al. Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis. Ann Neurol. 2011;70(6):964-973.
9. Greenway MJ, Alexander MD, Ennis S, et al. A novel candidate region for ALS on chromosome 14q11.2. Neurology. 2004;63(10):1936-1938.
10. Sutedja NA, Sinke RJ, Van Vught PW, et al. The association between H63D mutations in HFE and amyotrophic lateral sclerosis in a Dutch population. Arch Neurol. 2007;64(1):63-67.
11. Veldink JH, Kalmijn S, Van der Hout AH, et al. SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS. Neurology. 2005;65(6):820-825.
12. Corcia P, Camu W, Halimi JM, et al. SMN1 gene, but not SMN2, is a risk factor for sporadic ALS. Neurology. 2006;67(7):1147-1150.
13. Slowik A, Tomik B, Wolkow PP, et al. Paraoxonase gene polymorphisms and sporadic ALS. Neurology. 2006;67(5): 766-770.
14. Ince PG, Highley JR, Kirby J, et al. Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology. Acta Neuropathol. 2011;122(6):657-671.
15. Yang W, Strong MJ. Widespread neuronal and glial hyperphosphorylated Tau deposition in ALS with cognitive impairment. Amyotroph Lateral Scler. 2012;13(2):178-193.
16. Sundar PD, Yu CE, Sieh W, et al. Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia. Hum Mol Genet. 2007;16(3):295-306.
17. Münch C, Prechter F, Xu R, et al. Frequency of a Tau genotype in amyotrophic lateral sclerosis. J Neurol Sci. 2005;236(1-2):13-16.
18. Schraen-Maschke S, Dhaenens CM, Delacourte A, et al. Microtubule-associated protein Tau gene: a risk factor in human neurodegenerative diseases. Neurobiol Dis. 2004; 15(3):449-460.
19. Guerreiro RJ, Washecka N, Hardy J, et al. A thorough assessment of benign genetic variability in GRN and MAPT. Hum Mutat. 2010;31(2):E1126-1140.
20. Caffrey TM, Wade-Martins R. The role of MAPT sequence variation in mechanisms of disease susceptibility. Biochem Soc Trans. 2012;40(4):687-692.
21. Zhong Q, Congdon EE, Nagaraja HN, et al. Tau isoform composition influences rate and extent of filament formation. J Biol Chem. 2012;287(24):20711-20719.
22. Crespo-Biel N, Theunis C, Van Leuven F. Protein Tau: prime cause of synaptic and neuronal degeneration in Alzheimer's disease. Int J Alzheimers Dis. 2012;2012: 251426.
23. Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293-299.
24. Trabzuni D, Wray S, Vandrovcova J, et al. MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies. Hum Mol Genet. 2012;21(18):4094-103.
25. Galimberti D, Scarpini E. Genetics of frontotemporal lobar degeneration. Front Neurol. 2012;3:52.
26. Schmidt S, Allen KD, Loiacono VT, et al. Genes and environmental exposures in veterans with amyotrophic lateral sclerosis: the GENEVA study. Rationale, study design and demographic characteristics. Neuroepidemiology. 2008;30(3):191-204.
27. Premi E, Padovani A, Borroni B. Frontotemporal Lobar Degeneration. Adv Exp Med Biol. 2012;724:114-127.
28. Choumert A, Poisson A, Honnorat J, et al. G303V Tau mutation presenting with progressive supranuclear palsy-like features. Mov Disord. 2012;27(4):581-583.
29. Charlesworth G, Gandhi S, Bras JM, et al. Tau acts as an independent genetic risk factor in pathologically proven PD. Neurobiol Aging. 2012;33(4):838.e7-838.e 11.
30. Jung HH, Bremer J, Streffer J, et al. Phenotypic variation of autosomal-dominant corticobasal degeneration. Eur Neurol. 2012;67(3):142-150.
31. van Eersel J, Bi M, Ke YD, et al. Phosphorylation of soluble Tau differs in Pick's disease and Alzheimer's disease brains. J Neural Transm. 2009;116(10):1243-1251.
32. Gozes I. Tau pathology and future therapeutics. Curr Alzheimer Res. 2010;7(8):685-696.
33. Namboori PK, Vineeth KV, Rohith V, et al. The ApoE gene of Alzheimer's disease (AD). Funct Integr Genomics. 2011;11(4):519-522.
34. Taes I, Goris A, Lemmens R, et al. Tau levels do not influence human ALS or motor neuron degeneration in the SOD1G93A mouse. Neurology. 2010;74(21):1687-1693.
35. Serre D, Montpetit A, Paré G, et al. Correction of population stratification in large multi-ethnic association studies. PLoS One. 2008;3(1):e1382.
36. State Council of the People's Republic of China. Administrative Regulations on Medical Institution.1994-09-01.